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Abstract 31 
The age-associated reduction of adult hippocampal neurogenesis (AHN), the formation and 32 
integration of new neurons in the adult hippocampus, has been associated with cognitive decline. 33 
Numerous factors have been shown to modulate this process, including dietary components. Frequent 34 
consumption of caffeine has been correlated with an increased risk of cognitive decline, but further 35 
evidence of a negative effect on AHN are limited to animal models. Here, we used a human 36 
hippocampal progenitor cell line to investigate the effects of caffeine on hippocampal progenitor 37 
integrity and proliferation. The effects of five caffeine concentrations (0mM=control, 38 
0.1mM~150mg, 0.25mM~400mg, 0.5mM~750mg, and 1.0mM~1500mg) were measured following 39 
acute (1 day) and repeated (3 days) exposure. Immunocytochemistry was used to quantify 40 
hippocampal progenitor integrity (i.e., SOX2- and Nestin-positive cells), proliferation (i.e., Ki67-41 
positive cells), cell count (i.e., DAPI-positive cells), and apoptosis (i.e., CC3-positive cells). We 42 
found that progenitor integrity was significantly reduced in supraphysiological caffeine conditions 43 
(i.e., 1.0mM~1500mg), but relative to the lowest caffeine condition (i.e., 0.1mM~150mg) only. 44 
Moreover, repeated exposure to supraphysiological caffeine concentrations (i.e., 1.0mM~1500mg) 45 
was found to affect proliferation, significantly reducing %Ki67-positive cells relative to control and 46 
lower caffeine dose conditions (i.e., 0.1mM~150mg and 0.25mM~400mg). Caffeine treatment did 47 
not influence apoptosis and there were no significant differences in any measure between lower doses 48 
of caffeine (i.e., 0.1mM, 0.25mM, 0.5mM) - representative of daily human caffeine intake - and 49 
control conditions. Our study demonstrates that dietary components such as caffeine can influence 50 
AHN and may be indicative of a mechanism by which diet affects cognitive outcomes. 51 
1 Introduction 52 
Adult hippocampal neurogenesis (AHN), the formation of new neurons from neural progenitor cells, 53 
has recently regained considerable attention, particularly in the human hippocampus (Kempermann et 54 
al., 2018; Lucassen et al., 2020). This highly vascularized ‘neurogenic niche’, retains developmental 55 
signals and morphogens that influence cell proliferation, differentiation, and survival throughout life 56 
(Gonçalves et al., 2016; Spalding et al., 2013). The rates at which these processes occur have been 57 
associated with hippocampal-dependent learning and memory functions (Cleland et al., 2009; Sahay 58 
et al., 2011; Snyder et al., 2005) and this association is particularly interesting when considering 59 
ageing and cognitive decline, during which hippocampal function typically deteriorates (Small et al., 60 
2002). Moreover, neural progenitor proliferation declines in rodents as ageing progresses (Heine et 61 
al., 2004; Rao et al., 2006) and this has been strongly correlated with impaired performance in spatial 62 
memory and learning tasks (Sahay et al., 2011; Villeda et al., 2011). 63 
This association with cognitive decline presents AHN as a unique target area for preventative 64 
interventions. Accordingly, rescuing later life neurogenesis has recently gained interest and a focus 65 
has been given to the factors that modulate neurogenesis (Baptista and Andrade, 2018). While 66 
neurogenesis is facilitated by the neurogenic niche, it is not only central nervous system-derived 67 
signals that influence AHN. Indeed, AHN is also modulated by both the external environment (Lledo 68 
et al., 2006) and the system milieu (Villeda et al., 2011; Yousef et al., 2019). For example, stress and 69 
sleep deprivation have been shown to reduce AHN (Gould et al., 1998; Hairston et al., 2005; 70 
Lucassen et al., 2010), while running increases neurogenesis (van Praag et al., 2005).  Moreover, 71 
these environmental factors have been similarly correlated with spatial learning and memory (Nilsson 72 
et al., 1999; Oomen et al., 2010; 2014), highlighting the possibility of leveraging behavioral 73 
interventions to target the neurogenic process and, consequently, cognitive ability. 74 
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Diet is another environmental factor that has been shown to influence the neurogenic process 75 
(Abbink et al., 2020; Miquel et al., 2018; Stangl and Thuret, 2009). Drosophila research shows that 76 
nutritional factors can influence the exit of neural hippocampal progenitors from quiescence (Chell 77 
and Brand, 2010; Spéder and Brand, 2014), and other  nutritional-based changes to the hippocampal 78 
progenitor pool have been likewise demonstrated across other species (Cavallucci et al., 2016; 79 
Sakayori et al., 2013; Spéder et al., 2011). For instance, in humans, the nutrient-sensing pathways: 80 
the mammalian target of rapamycin (mTOR), sirtuin, and insulin-like growth factor 1, have all been 81 
associated with hippocampal progenitor maintenance (de Lucia et al. 2020). However, the influence 82 
of nutrition and meal content on the hippocampal progenitor pool occurs in a complex manner, with 83 
the nature of change dependent on the food groups consumed. For instance, a high fat diet has been 84 
shown to decrease proliferation in rats (Lindqvist et al., 2006), while in contrast omega-3 fatty acids 85 
increase proliferation in lobsters (Beltz et al., 2007). Interestingly, these changes to proliferation 86 
directionally correspond with their associated cognitive outcomes, as omega-3 has been shown to 87 
improve cognitive outcomes, while high fat diets impair cognitive performance (Fotuhi et al., 2009; 88 
Witte et al., 2009; Winocur and Greenwood, 2005; Yam et al., 2019). Thus, the variable nature of 89 
meal content and its influence on AHN may provide a flexible and unique mechanism of regulating 90 
the neurogenic process within the human population. However, further defining the dietary 91 
components that affect the neurogenic process and their direction of influence is crucial before such 92 
dietary-based interventions can be developed.  93 
Caffeine, the most widely consumed psychostimulant in the world (Ferré, 2016), has been widely 94 
implicated as a cognitive modulator (Glade, 2010; Rosso et al., 2008). Caffeine consumption has 95 
traditionally been argued to produce health benefits on a neurological basis, including protection 96 
against cognitive decline in women aged over 65 years (Arab et al., 2011; Ritchie et al., 2007). 97 
However, we recently demonstrated a negative effect of caffeine on cognition, identifying caffeine as 98 
one of 22 metabolites predictive of cognitive decline in an ageing population, over a 13-year period 99 
(Low et al., 2019). Further evidence to support a negative effect of caffeine comes from animal 100 
models that focus on AHN. Specifically, when administered chronically, physiologically relevant 101 
doses of caffeine decreased neuronal precursor proliferation in rats (Wentz and Magavi, 2009), which 102 
was further correlated with impaired hippocampal-dependent learning and memory (Han et al., 103 
2007). However, due to in vivo imaging constraints (Ho et al., 2013), the effect of caffeine on the 104 
human neurogenic process has not yet been explored. With the mixed clinical evidence on the impact 105 
of caffeine on cognitive decline and its large-scale consumption worldwide, further investigation is 106 
warranted. Determining the effects of caffeine on the neurogenic process, and ultimately cognition, 107 
will contribute to our understanding of how diet affects these phenomena, which could assist in the 108 
development of appropriate interventions.  109 
Therefore, this study investigated the effects of caffeine on the human neurogenic process, focusing 110 
specifically on proliferation and hippocampal progenitor integrity. We used a human hippocampal 111 
progenitor cell line, for the first time, to investigate, (i) the effects of five caffeine concentrations, and 112 
(ii) the effects of acute and repeated exposure to caffeine – all on hippocampal progenitor integrity 113 
and proliferation. 114 
2 Materials and Methods 115 
2.1 Cell Line and Culture Conditions 116 
The human hippocampal progenitor cell line HPC0A07/03 (HPC; ReNeuron Ltd, Surrey, UK) was 117 
used in all experiments, as previously described (de Lucia et al., 2020; Smeeth et al., 2020). Briefly, 118 
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cells were cultured in reduced modified medium (RMM), namely Dulbecco’s Modified Eagle’s 119 
Media/F12 (DMEM:F12, Sigma), supplemented with 0.03% human albumin solution (Zenalb), 120 
100 µg/mL human apo-transferrin, 16.2 µg/mL human putrescine diHCl, 5 µg/mL human 121 
recombinant insulin, 60 ng/mL progesterone, 2 mM L-glutamine and 40 ng/mL sodium selenite. For 122 
proliferation, the medium also included 10 ng/mL human basic fibroblast growth factor (bFGF), 123 
20 ng/mL human epidermal growth factor (EGF) and 100 nM 4-hydroxytamoxifen (4-OHT). Cells 124 
were grown on tissue culture flasks (Nunclon, Denmark), incubated at 37°C, 5% CO2 and saturated 125 
humidity, and were routinely passaged at 80% confluency before being plated for experiments. 126 
2.2 Proliferation Assay 127 
The HPC proliferation assay was carried out as previously described (de Lucia et al., 2020; Smeeth et 128 
al., 2020).  Briefly, HPCs were seeded into two 96-well plates (Nunclon, Denmark) per experiment: 129 
one plate for acute (one-time) caffeine treatment, the other for repeated caffeine treatment. Plates 130 
were seeded at a density of 1.2 x 104, at P21 in caffeine-free proliferation media, with three technical 131 
replicates and three biological replicates. All cells, excluding the control conditions, received caffeine 132 
treatment 24 hours after seeding. Cells undergoing acute treatment were left undisturbed for 48 133 
hours, while cells undergoing repeated exposure received another caffeine treatment 24 hours after 134 
the initial treatment. Control conditions were incubated in caffeine-free proliferation media in all 135 
instances. Seventy-two hours after seeding, all plates were washed and fixed as previously described 136 
(de Lucia et al., 2020; Smeeth et al., 2020). Figure 1 depicts the assay timeline as per the two 137 
exposure conditions. For details on the proliferation assays and fixation methods see Supplementary 138 
material. 139 
2.3 Caffeine Treatments 140 
Caffeine (5g) was obtained from Sigma (MO, USA) in powdered form, with a molecular weight of 141 
194.19 g/mol. Caffeine conditions were as follows: control (no caffeine, media only); low (0.1mM, 142 
~150mg, ~1 cup); moderate (0.25mM, ~400mg, ~2-3 cups); high (0.5mM, ~750mg, ~5 cups); and 143 
supraphysiological (1.0mM, ~1500mg, ~10 cups), reflecting human intake habits and previous 144 
animal models (EFSA, 2015; Wentz and Magavi, 2009). Caffeine concentrations were calculated 145 
based on previous research stating that 150mg of caffeine, the mean caffeine content of a Starbucks 146 
cappuccino (Ludwig et al., 2014), is approximately equivalent to 0.1mM (Su et al. 2013a; 2013b). 147 
For full details on the caffeine treatments see Supplementary material. 148 
2.4 Immunocytochemistry 149 
Cell count, progenitor cell integrity, progenitor proliferation and cell death were visualized using 150 
4′,6-diamidino-2-phenylindole (DAPI), Nestin and SRY-Box Transcription Factor 2 (SOX2), Ki67, 151 
and cleaved caspase-3 (CC3), respectively, using immunocytochemistry as previously described (de 152 
Lucia et al., 2020; Smeeth et al. 2020). For protocol details, antibodies used, and representative 153 
images see Supplementary material. 154 
2.5 Image Analysis 155 
Immunostainings were quantified using CellInsight NXT High Content Screening (HCS) platform 156 
(ThermoScientific) and the HCS Studio Cell Analysis Software (Thermo Scientific), as previously 157 
described (de Lucia et al., 2020; Smeeth et al. 2020). This software quantifies the intensity of 158 
fluorescent stainings of each marker in user-defined regions, against the identification of individual 159 
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cells by nuclear staining. For details on the protocols and parameters used see Supplementary 160 
material. 161 
2.6 Statistical Analyses 162 
Data analyses were conducted using IBM SPSS Statistics 26 (IBM Ltd., Portsmouth, UK). All data 163 
were assessed for normality using probability-probability plots and the Kolmogorov-Smirnov test, 164 
and for homogeneity of variance using the Levene’s test. For data that did not conform to normality 165 
and/or homoscedasticity non-parametric statistical tests were applied. To evaluate differences 166 
between DAPI, Ki67, C33, and Ki67/CC3, a two-way analysis of variance (ANOVA) with a 167 
Bonferroni post hoc correction was applied. To evaluate differences in SOX2, Nestin and 168 
Nestin/SOX2 a series of Kruskal Wallis tests with Dunn’s post hoc corrections were applied. All tests 169 
carried out were two-sided and the alpha criterion used was p < .05. Data are represented as the mean 170 
(M) and standard error of the mean (SEM), or the median (Mdn) and interquartile range (IQR). 171 
3 Results 172 
3.1 Exposure to Caffeine Reduces Cell Number 173 
There was no significant interaction of caffeine concentration and exposure type, i.e., repeated versus 174 
acute caffeine treatment, on cell number, as measured by DAPI-positive cell density  (p = .947), nor 175 
was there a significant main effect of exposure (p = .580). However, as shown in Figure 2.A, there 176 
was a main effect of caffeine concentration on DAPI-positive cell density (p = .036), such that higher 177 
caffeine doses reduced cell number. However, due to issues of power, post hoc analyses revealed no 178 
specific differences between any of the caffeine conditions, but a trend for significance did emerge 179 
with respect to the supraphysiological dose (i.e., 1.0mM~1500mg) relative to the lowest caffeine 180 
dose (i.e., 0.1mM~150mg) with a 58.6% reduction in cell count observed (p = .058). 181 
3.2 Exposure to Supraphysiological Caffeine Concentrations Reduces Hippocampal 182 
Progenitor Integrity Compared with Lower Caffeine Doses Only 183 
There was no significant main effect of exposure on hippocampal progenitor integrity, as measured 184 
by both %Nestin-positive (p = .901) and %SOX2-positive (p = .917) cells.  However, as shown in 185 
Figure 3, there was a significant main effect of caffeine concentration on both %Nestin-positive (p = 186 
.034) and %SOX2-positive cells (p =.016), all while controlling for cell number.  187 
Post hoc analyses revealed that the supraphysiological caffeine concentration (i.e., 1.0mM ~ 188 
1500mg) significantly reduced the %Nestin-positive cells by 1.5% relative to the lowest caffeine 189 
concentration (i.e., 0.1mM ~150mg; p = .016; Figure 3.A). No significant differences in %Nestin-190 
positive cells for any of the caffeine concentrations relative to control were observed 191 
(0.1mM~150mg: p >.99; 0.25mM~400mg:  p > .99; 0.5mM~750mg: p > .99; 1.0mM~1500mg: p = 192 
.388). However, it should be noted that the supraphysiological caffeine dose was reduced relative to 193 
control conditions but did not survive multiple comparison correction (non-adjusted p = .039).  194 
Similar to Nestin data, post hoc analyses of %SOX2-positive cells revealed that the 195 
supraphysiological caffeine dose (i.e., 1.0mM ~ 1500mg) significantly reduced %SOX2-positve cells 196 
by 2.3%, again, relative to the lowest caffeine concentration (0.1mM~150mg, p = .013; Figure 3.C). 197 
Moreover, there was a trend for a significant reduction in %SOX2-positive cells in the 198 
supraphysiological caffeine dose relative to the moderate caffeine concentration, i.e., 199 
0.25mM~400mg, (p = .059). Again, no significant differences were observed relative to control 200 
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conditions (0.1mM~150mg: p = >.99; 0.25mM~400mg:  p > .99; 0.5mM~750mg: p > .99; 201 
1.0mM~1500mg: p = .304), however like with the Nestin data, %SOX2-positive cells in the 202 
supraphysiological caffeine condition were reduced relative to control but did not survive multiple 203 
comparison correction (non-adjusted p = .03).  204 
Unsurprisingly, a similar results pattern was observed for %Nestin/SOX2-positve cells. Specifically, 205 
no significant main effect of exposure (p = .868) was observed, but there was a significant main 206 
effect of caffeine on %Nestin/SOX2-positive cells (p = .021), with the supraphysiological 207 
concentration reducing %Nestin/SOX2-positve cells by 2.1% relative to the lowest caffeine 208 
concentration only (p = .016; Figure 3.E.). Moreover, the %Nestin/SOX2-positive cells for the 209 
supraphysiological dose was reduced compared with the control condition (non-adjusted p = .029) 210 
and the moderate caffeine concentration, i.e. 0.25mM~400mg (non-adjusted p = .008) but these did 211 
not survive multiple comparison correction. 212 
3.3 Repeated Exposure to Supraphysiological Caffeine Concentrations Reduces Hippocampal 213 
Progenitor Proliferation 214 
There was no significant interaction effect of caffeine and exposure on proliferation, as measured by 215 
the percentage of Ki67-positive cells (p = .102). However, as shown in Figure 4.A, there was both a 216 
significant main effect of exposure (p = .009) and caffeine concentration (p < .001) on the %Ki67-217 
positive cells, all while controlling for cell number. Specifically, repeated exposure to the 218 
supraphysiological caffeine concentration (i.e., 1.0mM ~ 1500mg) significantly reduced proliferation 219 
by 37% relative to control conditions (p = .001), by 39.5% relative to the lowest caffeine dose (i.e., 220 
0.1mM ~150mg; p < .001), and by 37.7% relative to the moderate caffeine dose (i.e., 0.25mM ~ 221 
400mg; p = .001). No significant differences were found between the control condition and the other 222 
caffeine concentrations, i.e., 0.1mM (p > .99), 0.25mM (p > .99), and 0.5mM (p = .446), nor were 223 
any significant differences observed for acute exposure, that is, a single, one-time caffeine treatment. 224 
3.4 Exposure to Caffeine does not Affect Apoptosis 225 
As depicted in Figure S2.A, there was no significant interaction of caffeine concentration and 226 
exposure on apoptosis, as measured by %CC3-positive cells (p = .616), nor was there a significant 227 
main effect of exposure (p = .571) or caffeine concentration (p = .474) – all while controlling for cell 228 
number. Furthermore, as shown in Figure S2.C, there was no significant interaction of caffeine 229 
concentration and exposure on proliferative cell death, as measured by %Ki67/CC3-positive cells, (p 230 
= .797), nor was there a significant main effect of exposure (p = .759) or caffeine concentration (p = 231 
.167) – again, all while controlling for cell number. 232 
4 Discussion 233 
In this study we explore the effects of acute and repeated caffeine exposure at different 234 
concentrations on hippocampal progenitor proliferation and integrity, using an in vitro hippocampal 235 
cellular model. We demonstrate that a repeated supraphysiological dose of caffeine, i.e., 236 
1.0mM~1500mg or ~10 cups of coffee, significantly reduces progenitor proliferation, as measured by 237 
%Ki67-positive cells, relative to the control condition (no caffeine) and to both the lowest (i.e., 238 
0.1mM~150mg or ~1 cup) and moderate (i.e., 0.25mM~400mg or 2-3 cups) caffeine concentrations. 239 
Moreover, the supraphysiological dose (~10 cups of coffee), whether acutely or repeatedly 240 
administered, negatively influences progenitor integrity, as measured by both %Nestin- and %SOX2-241 
positve cells, but only when compared with the lowest caffeine dose (~1 cup of coffee). Finally, we 242 
show that caffeine, irrespective of the degree of exposure or concentration, does not affect overall, or 243 
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proliferative, cell death, as measured by %CC3-positive cells and %Ki67/CC3-positive cells, 244 
respectively.  245 
Our finding that repeated treatment with a supraphysiological caffeine concentration, that is, intake of 246 
~10 cups of coffee, reduces hippocampal progenitor proliferation directly contrasts previous findings 247 
from Wentz and Magavi (2009), who used an animal model and observe that supraphysiological 248 
doses increase proliferation. However, this inconsistency could be attributed to differences in study 249 
design; all previous findings were from an animal model, and therefore are not entirely translatable to 250 
our own study design that uses a human in vitro cellular model. Furthermore, our study found no 251 
effect of lower caffeine doses on hippocampal neurogenesis, despite previous literature 252 
demonstrating a decrease in proliferation (Han et al., 2007; Wentz and Magavi, 2009). While the 253 
discrepancies between our findings and that of the previous literature could be a consequence of the 254 
different models used, it is more likely attributable to the different timescales investigated. While our 255 
study investigated repeated exposure over 72-hours of proliferation, Wentz and Magavi (2009) and 256 
Han et al. (2007) investigated caffeine exposure over seven days and four weeks, respectively. In the 257 
context of our work, while the supraphysiological caffeine concentration is strong enough to produce 258 
a detrimental effect over a short period of time, our 72-hour paradigm may be insufficient to replicate 259 
the results seen from chronic exposure with lower, more physiologically relevant doses. Therefore, 260 
future work should seek to extend our paradigm to explore the longer-term effects of chronic, rather 261 
than repeated treatment, with physiologically relevant caffeine concentrations. 262 
Previously unexplored within an in vitro model of HPCs, our findings relating to %Nestin- and 263 
%SOX2-positive cells may provide some insight into the mechanisms by which the 264 
supraphysiological caffeine dose influences proliferation. SOX2 has been implicated as an important 265 
requirement for the maintenance of self-renewal and pluripotency in human embryonic hippocampal 266 
progenitors (Fong et al., 2008), and this has been further demonstrated in adult neural hippocampal 267 
progenitors. Ferri et al. (2004) found that knocking down SOX2 leads to reduced proliferation and a 268 
depletion of the neural hippocampal progenitor pool – a finding seemingly consistent with our own. 269 
Indeed, we report a reduction in both %Nestin-, %SOX- and %Nestin/SOX2-positive cells, and 270 
simultaneously find no change in either the total %CC3-positive cells or %CC3/Ki67-positive cells 271 
(i.e., specifically proliferative cell death), suggesting that the observed decrease in proliferation 272 
following repeated supraphysiological caffeine treatment likely stems from changes in the 273 
hippocampal progenitor pool itself. Moreover, these early changes to the hippocampal progenitor 274 
pool may produce prolonged knock-on effects on differentiation, that not only include reduced 275 
neurogenesis but also morphological abnormalities of the resulting neurons (Cavallaro et al., 2008). 276 
While we find no statistically significant effect of supraphysiological caffeine doses on SOX2 277 
relative to control conditions, we believe that this could potentially be due to issues of power 278 
(Cremers et al., 2017), given that prior to post hoc adjustment, the supraphysiological concentration 279 
of ~10 cups of coffee shows a reduction in both %Nestin-, %SOX2- and %Nestin/Ki67-positve cells, 280 
all relative to control conditions. Furthermore, it is notable that hippocampal progenitor integrity was 281 
statistically assessed using non-parametric methods, which are typically less powerful than 282 
parametric equivalents (Siegel, 1957).  Therefore, it would be highly profitable for future research to 283 
include a greater sample size to more fully elucidate the effect of supraphysiological caffeine 284 
concentrations on hippocampal progenitor integrity.   285 
The precise mechanisms by which caffeine affects neurogenesis are widely unknown, but the 286 
observed changes to %SOX2-positive cells may provide some insight. Caffeine has commonly been 287 
associated with protein kinase B (PKB or Akt) signaling; specifically, it has been attributed to 288 
downregulating Akt signaling in a wide range of cell types, from HeLa to mouse epidermal cell lines 289 
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(Nomura et al., 2005; Saiki et al., 2011). Pertinently, Akt signaling has been linked with SOX2, 290 
having been shown to promote the expression of SOX2 adult hippocampal neural progenitor cells 291 
(Peltier et al., 2010). Furthermore, Akt signaling itself decreases with age, akin to SOX2 expression 292 
and AHN, but its reactivation has been shown to ameliorate age-related defects in neuronal 293 
development (Tang et al., 2019). It is therefore possible that our finding of reduced %SOX2-positve 294 
cells following supraphysiological caffeine treatment is a product of downregulated Akt signaling. 295 
To our knowledge, the effect of caffeine on Akt signaling within an HPC cell line has not yet been 296 
investigated, and therefore future research would be instrumental in validating a link between 297 
caffeine and SOX2 expression in HPCs and revealing whether this action could be mediated by Akt 298 
signaling.  299 
While our work reveals a negative effect of supraphysiological caffeine on human hippocampal 300 
progenitor integrity and proliferation, there are some limitations in that our model that may have 301 
influenced the extent to which caffeine affects the neurogenic process. For example, caffeine is 302 
metabolized in the liver by the enzyme CYP1A2, which accounts for approximately 90% of caffeine 303 
metabolism (Arnaud, 2011). Interestingly, a C/A polymorphism in intron 1 of the CYP1A2 gene 304 
appears to affect CYP1A2 enzymatic activity, and ultimately alter the rate of caffeine metabolism 305 
(Sachse et al., 2001). Indeed, Butler et al., (1992) defined CYP1A2 activity as being trimodally 306 
distributed, with slow, intermediate, and rapid metabolizers, as determined by caffeine urinary 307 
metabolite analyses. Essentially, the rates of caffeine clearance differ depend on an individual’s 308 
genetic variant, and therefore the amount of time that caffeine is present in the systemic environment 309 
is subject to interindividual differences. These differences in caffeine metabolic rates have been 310 
associated with differences in the risk of some neurodegenerative diseases, with individuals 311 
possessing the C allele, i.e., slow metabolizers, having decreased caffeine-related risk of Parkinson’s 312 
Disease (Chuang et al., 2016; Popat et al., 2011). Therefore, it is possible that this polymorphism 313 
may also mediate differences in the way caffeine affects AHN, especially considering that caffeine 314 
reaches the brain via the systemic environment. Our study measures the direct effect of caffeine 315 
exposure on hippocampal progenitor cells, without accounting for differential metabolic rates in the 316 
liver caused by the CYP1A2 polymorphism.  317 
Furthermore, while the caffeine concentrations used in our study reflect ‘intake’, this is not 318 
representative of peak plasma levels obtained following caffeine metabolism. Indeed, around 99% of 319 
caffeine is metabolized into paraxanthine, theobromine, and theophylline (Arnaud, 1993; Nehlig, 320 
2018) and, thus, only residual caffeine remains in the systemic environment. For instance, 321 
consumption of 160mg of caffeine, in the form of a hot coffee, was shown to produce an average 322 
peak plasma level of 3.74µg/mL, or 19.26µM, in humans (White Jr et al., 2016). The lowest caffeine 323 
concentration in our study, 0.1mM, represents approximately 150mg of caffeine (Su et al., 2013a; 324 
2013b), or one Starbucks cappuccino (Ludwig et al., 2014), whereas plasma caffeine levels typically 325 
reach between 20 to 50µM (Graham, 2001). Therefore, the levels of caffeine tested in this study 326 
reflect supranutritional doses, not the physiologically relevant concentrations that would reach the 327 
neurogenic niche in vivo. However, this study provides proof of concept that caffeine can modulate 328 
the neurogenic process, and it would be profitable for future research to investigate the effects of 329 
nutritional and supranutritional caffeine concentrations on neurogenesis over time. 330 
Finally, although our aim was to explore the effect of caffeine on hippocampal progenitor cells, given 331 
that diet has been shown to specifically influence neural hippocampal progenitor behavior (Sakayori 332 
et al., 2013; Spéder et al., 2011), our work only narrowly focuses on the neurogenic process.  By only 333 
investigating proliferation, we do not know what longer-term, knock-on effects might arise from 334 
caffeine treatment, with respect to differentiation and/or survival. Therefore, future work should seek 335 
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to extend our paradigm to also evaluate the impact of caffeine on differentiation and neuron 336 
morphology.   337 
However, despite these limitations to our work, this study is the first, to our knowledge, to investigate 338 
the direct effects of caffeine on the neurogenic process using a human in vitro cellular model. 339 
Neurogenesis is influenced by a range of systemic and environmental factors that are difficult to 340 
control for in an in vivo environment (Azari and Reynolds, 2016) – an issue that is mostly controlled 341 
for in in vitro models. Moreover, species and strain differences have long been a criticism of animal 342 
models (Martić-Kehl et al., 2012), and AHN in particular has been shown to widely differ amongst 343 
mammalian species (Amrein et al., 2011). Therefore, our work investigates the direct effect of 344 
caffeine the human neurogenic process and is thus likely to yield results with greater translational 345 
value.  346 
In summary, our study demonstrates that dietary components such as caffeine can influence 347 
hippocampal neurogenesis and may be indicative of one mechanism by which diet affects cognitive 348 
outcomes. However, future research that (i) further explores the effects of human consumption-349 
related caffeine doses on neural progenitor proliferation and differentiation, and (ii) correlates this 350 
with cognitive outcomes, are needed to validate an association with caffeine, AHN, and cognitive 351 
decline. 352 
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Figure 1. Schematic of the proliferation assays for the two caffeine exposure conditions. (A) Acute 
caffeine exposure. This plate received only one caffeine treatment, 24 hours after seeding. Treatment 
involved a full replacement of culture medium with 100µl caffeinated medium. (B) Repeated Caffeine 
Exposure. This plate received a treatment every 24hrs after seeding. Treatment 1 (Tr1) involved a full 
replacement of culture medium with 100µl caffeinated medium. Treatment 2 (Tr2) involved a ‘booster’ 
treatment, where 20µl of medium was removed and replaced with fresh caffeine medium. Booster 
treatments were made at 5x concentration. Both plates were fixed 72 hours after seeding. ICC; 
immunocytochemistry. Cell line: HPC0A07/03. Passage number: P21; Biological replicates: n=3; 
Technical replicates: n=3. 
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Figure 2. The effect of caffeine treatment on DAPI-positive cell density. (A). There was no significant interaction of caffeine concentration and exposure 
on DAPI-positive cell density (Two-way ANOVA: F [4, 20] = .179, p = .947), nor was there a significant main effect of exposure (F [1, 20] =.317, p = .580). 
However, caffeine had a significant main effect on DAPI-positive cell density (One-way ANOVA: F [4, 25] = 3.041, p = .036). Post hoc analyses revealed no 
significant differences in total cell number between any specific caffeine concentration and the control, nor between any caffeine concentrations, but a trend for 
significance emerged for the supraphysiological caffeine concentration (i.e., 1.0mM, M = 74.13, SD = 34.27) having reduced cell count compared with the 
lowest caffeine concentration (i.e., 0.1mM, M = 171.12, SD = 74.21, p = .058). (B). Representative immunostaining, demonstrating DAPI-positive cell density 
following exposure to different caffeine concentrations. Images taken at 10x objective; scale bar represents 100µM. Cell line: HPC0A07/03; Passage number: 
P21; Biological replicates: n=3; Technical replicates: n=3; Data represents the mean (± SEM); (adjusted p values; Bonferroni correction). Note: Graph not 
stratified by exposure given that no interaction or main effect of exposure was found. 
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Figure 3. The effect of caffeine treatment on %Nestin-, %SOX2-, and Nestin/SOX2-positive cells. (A). There was no significant main effect of exposure 
on %Nestin-positive cells (Kruskal-Wallis test, H = .02, df. = 1, p = .901) but there was a significant main effect of caffeine (Kruskal-Wallis test, H = 10.38, 
df. = 4, p = .034). Dunn’s post hoc analyses revealed that the supraphysiological caffeine concentration (i.e., 1.0mM; Mdn = 97.2, IQR = 1.99) had significantly 
reduced stem cell integrity compared with the lowest caffeine concentration (i.e., 0.1mM, Mdn = 98.66, IQR = .72, p = .016). (B). Representative 
immunostaining, demonstrating DAPI-positive cell density with %Nestin-positive cells following exposure to different caffeine concentrations. Images taken 
at 10x objective; scale bar represents 100µM. (C) There was no significant main effect of exposure on %SOX2-positive cells (Kruskal-Wallis test, H = .01, df. 
= 1, p = .917) but there was a significant main effect of caffeine (Kruskal-Wallis test, H = 12.17, df. = 4, p = .016). Dunn’s post hoc analyses revealed that the 
supraphysiological caffeine concentration (i.e., 1.0mM; Mdn = 96.59, IQR = 2.8) was significantly reduced compared with the lowest caffeine concentration 
(i.e., 0.1mM, Mdn = 98.9, IQR = 0.81, p = .013). (D) Representative immunostaining, demonstrating DAPI-positive cell density with %SOX2-positive cells 
following exposure to different caffeine concentrations. Images taken at 10x objective; scale bar represents 100µM. (E). There was no significant main effect 
of exposure on %Nestin/SOX2-positive cells (Kruskal-Wallis test, H = .03, df. = 1, p = .868) but there was a significant main effect of caffeine (Kruskal-Wallis 
test, H = 11.61, df. = 4, p = .021). Dunn’s post hoc analyses revealed the supraphysiological caffeine concentration (i.e., 1.0mM; Mdn = 95.46, IQR = 3.98) 
was significantly reduced compared with the lowest caffeine concentration (i.e., 0.1mM, Mdn = 97.48, IQR = 1.11, p = .016). (F). Representative 
immunostaining, demonstrating DAPI-positive cell density with %Nestin/SOX2-positive cells following exposure to different caffeine concentrations. Images 
taken at 10x objective; scale bar represents 100µM.  %Nestin-, %SOX2-, and %Nestin/SOX2-positive cells are controlled for by DAPI. Graphs not stratified 
by exposure given that no main effect of exposure was found. Cell line: HPC0A07/03; Passage number: P21; Biological replicates: n=3; Technical replicates: 
n=3; Data represents the median (± IQR); * p < .05; (adjusted p values; Dunn’s correction). 
E. F. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The effect of caffeine treatment on %Ki67-positive cells. (A) There was no significant interaction effect of caffeine concentration and exposure on 
%Ki67-positive cells (Two-way ANOVA: F [4, 20] = 2.235, p = .102). However, a significant main effect of both exposure (Two-Way ANOVA: F [1, 20] = 
8.292, p = .009) and caffeine concentration (Two-way ANOVA: F [4, 20] = 9.81, p < .001) was found on %Ki67-positive cells. Specifically, Bonferroni post 
hoc analyses revealed that repeated treatment with the supraphysiological concentration (i.e., 1.0mM; M = 39.05, SD = 7.5) significantly reduced proliferation 
compared with the control (M = 61.94, SD = 6.69, p = .001), the lowest caffeine  dose (i.e., 0.1mM; M = 64.580, SD = 4.403, p < .001), and the moderate 
caffeine dose (i.e., 0.25mM; M = 62.68, SD = 6.35, p = .001). (B). Representative immunostaining, demonstrating DAPI-positive cell density with %SOX2-
positive cells following repeated exposure to different caffeine concentrations. Images taken at 10x objective; scale bar represents 100µM. %Ki67-positive cells 
are controlled for by DAPI. Cell line: HPC0A07/03; Passage number: P21; Biological replicates: n=3; Technical replicates: n=3; Data represents the mean (± 
SEM); ** p < .01 (adjusted p values; Bonferroni correction). 
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1 Supplementary Methods 
1.1 Proliferation Assay 
The hippocampal progenitor cell (HPC) proliferation assay was carried out as previously described 
(de Lucia et al., 2020; Smeeth et al., 2020).  Briefly, HPCs were seeded into two 96-well plates 
(Nunclon, Denmark) per experiment: one plate for acute (one-time) caffeine treatment, the other for 
repeated caffeine treatment. Plates were seeded at a density of 1.2 x 104, at P21, with three technical 
replicates and three biological replicates. After seeding, cells were cultured in proliferation medium 
(reduced modified medium (RMM), with human epidermal growth factor (EGF), human basic 
fibroblast growth factor (bFGF), and 4-hydroxytamoxifen (4-OHT) for 24 hours, after which the 
media was replaced by caffeine supplemented proliferation media (i.e., full treatment) for 48 hours. 
The acute treatment condition was left undisturbed for 48 hours, while the repeated condition 
received another caffeine treatment 24 hours later, where 20µl of the caffeine supplemented 
proliferation media was removed and replaced with a concentrated caffeine dose (i.e., booster 
treatment). Control conditions were incubated in caffeine-free proliferation media in all instances. 
Seventy-two hours after seeding, plates were washed with phosphate buffered saline (PBS) and fixed 
with 4% paraformaldehyde (PFA) for 20 minutes at room temperature. Post-fixation, plates were 
washed and stored in PBS with sodium azide (NaN3; 0.05% dilution) at 4°C in preparation for 
immunocytochemistry. 
1.2 Caffeine Treatments 
Prior to experimentation, caffeine concentrations were measured and dissolved in proliferation 
medium (RMM, with EGF, bFGF, and 4-OHT) separately for the two treatment types (i.e.., full and 
booster). As full treatments involved completely replacing the proliferation media, these were made 
at 1x the intended concentration. For repeated exposure, booster treatments at 5x the intended 
concentration were used, and 20µl of the total 100µl media was replaced to prevent interfering with 
the cell-produced factors. All caffeine concentrations (i.e., full and booster) and control proliferation 
media were clarified, aliquoted and frozen at -4°C for future use. Since caffeine content has been 
shown to differ depending on brewing method (Bell et al., 1996), to minimize any changes in 
caffeine concentration, all caffeine and control aliquots were defrosted in the 37°C water bath for ten 
minutes and clarified before use. All aliquots were thawed only once prior to use. 
1.3 Immunocytochemistry 
To quantify proliferation and progenitor cell integrity, immunocytochemistry was used as previously 
described (de Lucia et al., 2020; Smeeth et al. 2020). Briefly, PFA-fixed cells were incubated for 1h 
at room temperature in blocking solution, consisting of PBS-NaN3 with 5% normal donkey serum 
(D9963, Sigma) and 0.3% Triton-X (93443, Sigma). Cells were then incubated in 30µl of primary 
antibodies: Ki67 for proliferation, (Mouse anti-Ki67, 1:800, Cell Signalling Technology), Cleaved 
Caspase 3 for apoptosis (CC3; rabbit anti-CC3, 1:500, Cell Signalling Technology), and Nestin and 
SOX2 for hippocampal progenitor integrity (Mouse anti-Nestin, 1:1000, Merck Millipore; Mouse 
anti-Nestin, 1:1000, Abcam) - all diluted in blocking solution overnight at 4°C. Cells were then 
washed twice with PBS, and incubated in blocking solution for 30 minutes at room temperature, 
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before being incubated in 30µl of secondary antibodies (Alexa 488 donkey anti-mouse, 1:500, Life 
Technologies, A-21202; Alexa 555 donkey anti-rabbit, 1:500, Life Technologies, A-31572), diluted 
in blocking solution, for 2h at room temperature in the dark. Cells were then washed twice with PBS 
and incubated at room temperature for 5 minutes in 50µl of 300µm 4′,6-diamidino-2-phenylindole 
solution diluted in PBS (DAPI; D9542-5mg, Sigma). Finally, cells were washed twice more before 
being stored in 200µl PBS with NaN3 (0.05% dilution) at 4°C in the dark.  
1.4 Image Analysis 
In brief, images were taken with a 10x objective that autofocuses using the DAPI stain. Exposure 
time was manually defined to ensure a good signal to noise ratio. Individual cells were determined 
using the DAPI-positive nuclei, and smoothing, threshold, and segmentation parameters were 
modified as required to ensure accurate outlining of nuclei. Consequently, DAPI stains too small or 
large to be counted as nuclei were excluded.  
Cellular markers of interest were then identified and quantified, with defined parameters that were 
dependent on each marker’s location in relation to the nucleus. Nuclear proteins were indicated using 
a round target that overlaid the nuclear outline. Conversely, cytoplasmic proteins were indicated 
using a donut target, where the nucleus was denoted with the target’s inner boundary. Average 
intensity thresholds (AIT) were manually defined, to distinguish specific fluorescent signals from 
unspecific binding and background noise. To set these, the experimental wells were compared to the 
negative control wells (i.e. without primary antibodies), and the threshold was set above the highest 
intensity signal of the negative control. Consequently, the positive cells (those with an AIT above the 
set threshold) could be differentiated from the negative cells (AIT below the set threshold). These 
parameters were kept constant throughout every experiment. Once the parameters had been set, plates 
were scanned. Fifteen fields per well were captured, in which the software calculates the percentage 
of all cells positive for each marker (identified by the appropriate cellular stain), as controlled for by 
DAPI-positive nuclei. 
 
 
 
 
 
 
 
 
 
 3 
2 Supplementary Figures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. Representative images of immunostaining. Each box represents a field analysed by the Cell Insight 
software. Row 1 represents (from left to right) Ki67 in pink, CC3 in green, and Ki67/CC3. Row 2 represents 
(from left to right) Nestin in green, SOX2 in pink, and Nestin/SOX2. DAPI stainings are shown in dark blue in 
all images. Images taken with at 10x objective; scale bar, on the bottom left box, represents 100µM. Cell line: 
HPC0A07/03; Passage number: P21. 
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Figure S2. The effect of caffeine treatment %CC3- and %CC3/Ki67-positive cells. (A). There was no significant main effect of caffeine (One-way 
ANOVA: F [4, 25] = 9.09, p = .474), exposure (Two-way ANOVA: F [1, 20] = .331, p = .571), nor an interaction effect (Two-way ANOVA: F [4, 20] = 
.677, p = .616) on apoptosis, that is %CC3-positive cells. (B). Representative immunostaining, demonstrating DAPI-positive cell density with %CC3-
positive cells, following exposure to different caffeine concentrations. Images taken at 10x objective; scale bar represents 100µM. (C). There was no 
significant main effect of caffeine (One-way ANOVA: F [4, 25] =1.767, p = .167), exposure (Two-way ANOVA: F [1, 20] = .097, p = .759), nor an 
interaction effect (Two-way ANOVA: F [4, 20] = .413, p = .797) on %CC3/Ki67-positive cells. (D). Representative immunostaining, demonstrating DAPI-
positive cell density with %CC3/Ki67-positive cells following exposure to different caffeine concentrations. Images taken at 10x objective; scale bar 
represents 100µM. %CC3- and %CC3/Ki67-positive cells are controlled for by DAPI. Graphs not stratified by exposure given that no main effect of 
exposure was found. Cell line: HPC0A07/03; Passage number: P21; Biological replicates: n=3; Technical replicates: n=3; Data represents the mean (± 
SEM) (adjusted p values; Bonferroni correction). 
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